Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter.
Drugmaker Pfizer said Monday it will wind down clinical trials in Russia while allowing its medicines to continue to flow into the country for compassionate reasons, using any proceeds for humanitarian assistance in Ukraine.
The federal government needs to look strategically at how they spend taxpayer cash on medical technology. They should consider the efficient allocation of medicine and safety when setting priorities. We have come a long way since an extra vaccine was tossed in the trash and medical professionals learned there was massive destruction of unused vaccines for no good reason.